{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:55:56Z","timestamp":1777373756103,"version":"3.51.4"},"reference-count":10,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Context.\u2014Previous studies have demonstrated p63 overexpression in giant cell tumors of bone and advocate its use as a potential diagnostic marker. Although routine histology is often all that is required to diagnose giant cell tumor of bone, immunohistochemistry could prove useful to distinguish it from other benign and malignant giant cell\u2013containing lesions of bone and soft tissue on needle biopsies and unusual clinical settings.<\/jats:p>\n                  <jats:p>Objective.\u2014To assess p63 expression in giant cell\u2013containing lesions of bone and soft tissue.<\/jats:p>\n                  <jats:p>Design.\u2014p63 immunohistochemistry was performed in 23 giant cell tumors of bone, 8 primary aneurysmal bone cysts, 12 chondroblastomas, 4 giant cell reparative granulomas, 4 osteosarcomas, 15 tenosynovial giant cell tumors, 6 nonossifying fibromas, and 4 pigmented villonodular synovitides.<\/jats:p>\n                  <jats:p>Results.\u2014p63 overexpression was identified in 20 of 23 giant cell tumors of bone (86.9%), 5 of 8 primary aneurysmal bone cysts (62.5%), 10 of 12 chondroblastomas (83.3%), 4 of 4 giant cell reparative granulomas (100%), 2 of 4 osteosarcomas (50%), 1 of 15 tenosynovial giant cell tumors (6.6%), 1 of 6 nonossifying fibromas (16.6%), and 1 of 4 pigmented villonodular synovitides (25%). The sensitivity, specificity, positive predictive value, and negative predictive value of p63 immunohistochemistry for the diagnosis of giant cell tumor of bone were 86.95%, 53.36%, 45.45%, and 91.17%, respectively.<\/jats:p>\n                  <jats:p>Conclusions.\u2014This study shows that although p63 is expressed by most giant cell tumors of bone, its lack of specificity limits its use as an immunohistochemical marker in the differential diagnosis of giant cell\u2013containing lesions of bone and soft tissue.<\/jats:p>","DOI":"10.5858\/2010-0291-oa.1","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T13:37:14Z","timestamp":1613137034000},"page":"776-779","source":"Crossref","is-referenced-by-count":33,"title":["p63 Expression in Giant Cell\u2013Containing Lesions of Bone and Soft Tissue"],"prefix":"10.5858","volume":"135","author":[{"given":"Gustavo","family":"de la Roza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","reference":[{"key":"2021021104305043700_i1543-2165-135-6-776-b01","first-page":"263","article-title":"Giant cell tumor (osteoclastoma).","author":"Unni","year":"1996","journal-title":"Dahlin's Bone Tumors: General Aspects and Data on 11,087 Cases. 5th ed"},{"key":"2021021104305043700_i1543-2165-135-6-776-b02","first-page":"309","article-title":"Giant cell tumour.","author":"Reid","year":"2002","journal-title":"World Health Organization Classification of Tumours, Pathology and Genetics of Soft Tissue and Bone"},{"issue":"2","key":"2021021104305043700_i1543-2165-135-6-776-b03","first-page":"494","article-title":"p63 expression profiles in human normal and tumor tissues.","volume":"8","author":"Di Como","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"6729","key":"2021021104305043700_i1543-2165-135-6-776-b04","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/19539","article-title":"p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development.","volume":"398","author":"Yang","year":"1999","journal-title":"Nature"},{"issue":"6729","key":"2021021104305043700_i1543-2165-135-6-776-b05","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/19531","article-title":"p63 is a p53 homologue required for limb and epidermal morphogenesis.","volume":"398","author":"Mills","year":"1999","journal-title":"Nature"},{"issue":"12","key":"2021021104305043700_i1543-2165-135-6-776-b06","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1097\/01.MP.0000038460.95912.6E","article-title":"Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells.","volume":"15","author":"Weinstein","year":"2002","journal-title":"Mod Pathol"},{"issue":"8","key":"2021021104305043700_i1543-2165-135-6-776-b07","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/00000478-200108000-00010","article-title":"p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.","volume":"25","author":"Barbareschi","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2021021104305043700_i1543-2165-135-6-776-b08","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/modpathol.2008.29","article-title":"Giant cell tumor of bone express p63.","volume":"21","author":"Dickson","year":"2008","journal-title":"Mod Pathol"},{"issue":"5","key":"2021021104305043700_i1543-2165-135-6-776-b09","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/modpathol.3801023","article-title":"Gene expression profiling identifies p63 as a diagnostic marker of giant cell tumor of bone.","volume":"21","author":"Lee","year":"2008","journal-title":"Mod Pathol"},{"issue":"suppl 1s","key":"2021021104305043700_i1543-2165-135-6-776-b10","first-page":"18A","article-title":"Giant cell lesions of bone and soft tissues: diagnostic value of immunohistochemistry [abstract].","volume":"22","author":"Linden","year":"2009","journal-title":"Mod Pathol"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/135\/6\/776\/2771127\/2010-0291-oa_1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/135\/6\/776\/2771127\/2010-0291-oa_1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:33:19Z","timestamp":1764790399000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/135\/6\/article-p776.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,1]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6,1]]}},"URL":"https:\/\/doi.org\/10.5858\/2010-0291-oa.1","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,1]]}}}